Delta Gold Appoints Dr Thomas Davis to Newly Formed Strategic Advisory Panel (DGQ)

Delta Gold Technologies plc (AQSE:DGQ) (USOTC:DGQTF) has appointed Dr Thomas P Davis as a Strategic Advisor and the inaugural member of its newly created Strategic Advisory Panel as the company seeks to strengthen its scientific research and intellectual property capabilities.

The Strategic Advisory Panel has been established to assist Delta’s board and executive team in evaluating, prioritising and implementing research and development investments. Its remit will focus on identifying commercially attractive technologies, partnership opportunities and intellectual property initiatives that could support the company’s long-term innovation strategy.

Delta said the panel is expected to include specialists from scientific, engineering and industrial disciplines, providing expertise across areas such as due diligence, risk assessment and strategic oversight relating to the company’s developing technology portfolio.

Dr Thomas P Davis is co-founder and chief executive of Oxford Sigma and has extensive experience in advanced materials technologies spanning the fusion, nuclear and broader emerging technology sectors.

He also serves as chair of the American Society of Mechanical Engineers Boiler and Pressure Vessel Code Section III Division 4 committee, contributing to international standards development for fusion energy systems.

Dr Davis holds a doctorate in Materials Science from University of Oxford and a Master of Engineering degree in Nuclear Engineering from University of Birmingham. He is additionally recognised as both a Chartered Engineer and Chartered Scientist through the Institute of Materials Minerals and Mining.

According to Delta Gold, Dr Davis will advise the company on future research investments, advanced materials applications and engineering considerations linked to its technology roadmap. He is also expected to assist in identifying collaboration opportunities with industrial and academic partners.

Chief Executive R. Michael Jones described the appointment as an important milestone in strengthening the company’s research and intellectual property strategy, highlighting Dr Davis’ expertise in advanced materials innovation and commercialisation across highly technical scientific industries.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *